Clinical Trial Update: PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A） [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Prothrombin Complex Concentrate (PCC) for hemophilia patients with inhibitors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Prothrombin Complex Concentrate (PCC) (prothrombin complex concentrate)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia, Inhibitors | Phase 4 | Status: RECRUITING